# 18F-CP18 Imaging Studies for Cancer Treatment With Birinapant

> **NCT01766622** · PHASE2 · WITHDRAWN · sponsor: **National Institutes of Health Clinical Center (CC)**

## Conditions studied

- Ovarian Neoplasms
- Ovarian Cancer
- Fallopian Tube Neoplasms
- Fallopian Tube Cancer

## Interventions

- **DRUG:** [18F]-CP18
- **PROCEDURE:** PET/ CT

## Key facts

- **NCT ID:** NCT01766622
- **Lead sponsor:** National Institutes of Health Clinical Center (CC)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-11-30
- **Primary completion:** 2013-07-24
- **Final completion:** 2013-07-24
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2019-12-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01766622

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01766622, "18F-CP18 Imaging Studies for Cancer Treatment With Birinapant". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01766622. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*